Vatalanib dihydrochloride
Grundinformationen
- CAS
212141-51-0- Standard-SMILES
Cl.Cl.Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1- InChIKey
AZUQEHCMDUSRLH-UHFFFAOYSA-N- Summenformel
- C20H17Cl3N4
- Durchschnittliche Molmasse
- 419,7 g/mol
- Monoisotopische Masse
- 418,05187958
Überblick
Vatalanib dihydrochloride is a member of phthalazines.
Namen und Bezeichner
- Bevorzugter Name
- Vatalanib dihydrochloride
- IUPAC
- N-(4-chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine;dihydrochloride
- Englischer Name
- Vatalanib Dihydrochloride
- Summenformel
- C20H17Cl3N4
- Molmasse
- 419.74
Namen und Synonyme
Vatalanib dihydrochloride212141-51-0DTXSID5049073DTXCID6028999RefChem:388334Vatalanib 2HClVatalanib (PTK787) 2HClN-(4-Chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine dihydrochloridePTK/ZKVatalanib HClN-(4-Chlorophenyl)-4-(4-pyridinylmethyl)-1-phthalazinamine DihydrochlorideVatalanib (dihydrochloride)
Weitere Namen anzeigen
CS-465CGP-79787ZK-222584CGP-79787DCGP79787) 2HClVatalinib 2HClPTK787 dihydrochlorideVatalanib 2HCl (PTK787)
s1101AKOS005146306NCGC00181350-02AS-58428N-(4-chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine;dihydrochlorideVatalanib?3AMG9AK8TJEC-000.2362
Datenbank-Bezeichner
- CAS
212141-51-0- PubChem CID
- 22386467
- DTXSID
DTXSID5049073- ChEMBL
CHEMBL2142861- ChEBI
CHEBI:228537- UNII
- 3AMG9AK8TJ
Eigenschaften
Berechnete Struktureigenschaften
- Polarare Oberfläche (TPSA)
- 50,7 Ų
- H-Brücken-Donoren
- 3
- H-Brücken-Akzeptoren
- 4
- Frei drehbare Bindungen
- 4
- Schwere Atome
- 27
- Formalladung
- 0
- Komplexität
- 407
Physikochemische Eigenschaften
- Schmelzpunkt
- 268 · 268-2700C
- storage temp.
- -20 °C · Inert atmosphere,Store in freezer, under -20°C
- Löslichkeit
- Soluble in DMSO (up to 20 mg/ml with warming) or in Water (up to 100 mg/ml)
- Aggregatzustand
- solid
- Farbe
- White or off-white
- Wasserlöslichkeit
- 2 O: · H2O: 2mg/mL, clear
- Stabilität
- 2 years · Stable for 2 years from date of purchase as supplied. Solutions in DMSO or distilled water may be stored at -20°C for up to 3 months.
- InChI
- 1S/C20H15ClN4.2ClH/c21-15-5-7-16(8-6-15)23-20-18-4-2-1-3-17(18)19(24-25-20)13-14-9-11-22-12-10-14;;/h1-12H,13H2,(H,23,25);2*1H
- InChIKey
- AZUQEHCMDUSRLH-UHFFFAOYSA-N
- SMILES
- ClC(C=C1)=CC=C1NC2=NN=C(CC3=CC=NC=C3)C4=CC=CC=C42
- CAS Datenbank
- 212141 · 212141-51-0
Sicherheit und Regulatorisches
Sicherheitsdaten
- wgk
- WGK 3
- hs_code
- 29333990
- risk_code
- 36/37/38
- safety_code
- 24/25
- Speicherklasse
- 11 - Combustible Solids
Chemie und Industrie
Anwendungen
BeschreibungVatalanib is an antagonist of the VEGF receptors, inhibiting the receptor tyrosine kinase activities of VEGFR1 (Flt1), VEGFR2 (KDR), and VEGFR3 (Flt4) with IC50 values of 77, 37, and 190 nM, respectively. It less potently inhibits PDGF and c-Kit (IC50 = 600 and 700 nM) and has no effect on a large panel of additional kinases. Vatalanib completely blocks retinal neovascularization in oxygen-induced ischemic retinopathy in mice, suggesting its use in diabetic retinopathy and other diseases featuring aberrant vascular development.
VerwendenVascular endothelial growth factor (VEGF) receptor tyrosine kinase inhibitor. Antineoplastic.
Anbieter91 Anbieter
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
上海凌富药物研究有限公司+86(21)5895 0110 19945755304 · [email protected]
南通飞宇生物科技有限公司0513-68819626 15152877458 · [email protected]
武汉英诺医药科技有限公司+86-027-59232304 15387063101 · [email protected]
上海麦克林生化科技股份有限公司021-50706066 15221275939 · [email protected]
河南赢创生物科技有限公司16650615803 · [email protected]
上海毕得医药科技股份有限公司400-1647117 13681763483 · [email protected]
武汉众志诚生物技术有限公司13628624121 13628604890 · [email protected]
Dayang Chem (Hangzhou) Co.,Ltd.+86-0571-88938639 17705817739 · [email protected]
北京索莱宝科技有限公司010-50973130 17801761073 · [email protected]
大连美仑生物技术有限公司0411-62910999 13889544652 · [email protected]
常州科化生物科技有限公司0519-68985668 13685222090 · [email protected]
欧利希(湖北)医药科技有限公司17316404525 17316404525 · [email protected]
United Life Science020-82099279 18988941402 · [email protected]
InvivoChem中国13549236410 · [email protected]
MedBio脉铂医药021-69568360 18916172912 · [email protected]
北京博奥森生物技术有限公司400-901-9800 18611424007 · [email protected]
Zhejiang J&C Biological Technology Co.,Limited+1-2135480471 · [email protected]
济南精合医药科技有限公司0531-88811783 · [email protected]
ChemeGen 中国18818260767 · [email protected]
上海思域化工科技有限公司86-21-34053660 · [email protected]
Wuhan NCE Biomedical Co.,Ltd.4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988
江苏艾康生物医药研发有限公司025-66113011 13913916777 · [email protected]
PT CHEM GROUP LIMITED+86-85511178; +86-85511178 · [email protected]
上海将来实业股份有限公司021-61552785 · [email protected]
HBCChem, Inc.+1-510-219-6317 · [email protected]
上海毕得医药科技股份有限公司400-164-7117 18317119277 · [email protected]
天津普西唐生物医药科技有限公司010-60605840 · [email protected]
南京百鑫德诺生物科技有限公司025-58849295 · [email protected]
凯试(上海)科技有限公司021-50135380 · [email protected]
上海楼岚生物科技有限公司021-52996696,15000506266 15000506266
武汉天植生物技术有限公司18607101326 15172504745 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354; +1-00000000000 · [email protected]
安耐吉化学&3A(安徽泽升科技股份有限公司)400-0056266 · [email protected]
艾吉析科技(上海)有限公司17721401538;17717235263 17721401538 · [email protected]
武汉多普乐生物医药有限公司+86-02787215551 19945035818 · [email protected]
风咏生物(AbMole)021-10000000 13000000000 · [email protected]
上海珞珐生化科技有限公司021-51111890 15317326293 · [email protected]
药渡经纬信息科技(北京)有限公司+86-400-851-9921 · [email protected]
兰州安杰利生物化学科技有限公司0931-8235634 13321316780
广州市齐云生物技术有限公司020-61288194 61288195 · [email protected]
上海前衍生物科技有限公司02781293128 · [email protected]
上海源叶生物科技有限公司13636370518 · [email protected]
Target molecule Corp.857-239-0968 · [email protected]
天津凯利奇生物科技有限公司15076683720 · [email protected]
成都华纯科技有限公司400-1166-196 15982826727 · [email protected]
南京罗迈美生物科技有限公司[email protected]
Cckinase, Inc.+1 (732)236-3202 · [email protected]
威尔曼医药集团有限公司15807197853 18971451745 · [email protected]
苏州爱玛特生物科技有限公司0512-56316828 400-867-5858;400-867-5858 · [email protected]
Zugehörige Reaktionen
8
Notizen zur Verbindung
Wird geladen…